Marijuana Use Can Cause Schizophrenia

This statement can be made based on the Bradford Hill criteria. Visit the IASIC library to read more about the Bradford Hill criteria and various adverse effects of marijuana.

People argue the difference between causation and association. This was the same argument held 100 years ago with tobacco. How can one prove that black lungs and cancer were caused by tobacco?  It could have simply been an environmental association. The proof that tobacco caused cancer and lung disease, and not just associated with these diseases was made using the epidemiological criteria established by Sir Austin Bradford Hill in 1965.

What is psychosis?  Psychosis is a symptom of disruption to a person’s thoughts and perceptions that make it hard for them to differentiate what is real what isn’t. It includes hallucinations, seeing, hearing or feeling things that are not there. It also includes delusions, strong beliefs that are not true and seem irrational to others such as external forces controlling thoughts or believing in special powers. Psychosis is a symptom of schizophrenia.

What is schizophrenia?  Schizophrenia is a serious mental illness that distorts thinking, emotions, making decisions, and relating to others.

What is the difference between cannabis and marijuana?  According to the NIH, National Institute of Health, cannabis refers to all 540 chemical substances in the Cannabis sativa plant.  The term marijuana refers to parts or products of the Cannabis sativa plant that contains substantial amounts of THC, the psychoactive chemical. The medical literature uses the term cannabis and marijuana, and therefore IASIC uses both terms.

How can we prove that cannabis/ marijuana causes chronic psychosis or schizophrenia? The proof comes using various medical research articles that fit the 9 Bradford Hill criteria.

  1. Strength of the association
  2. Consistency and reproducibility of the evidence
  3. Specificity
  4. Temporality, the effect occurs after the cause the effect
  5. Biological gradient, a dose-response relationship
  6. Plausibility
  7. Coherence
  8. Experimental evidence
  9. Analogy – other drugs of abuse increase dopamine release in the brain and can result in a chronic psychotic disorder.

The currently available research on cannabis causing chronic psychotic disorders satisfies the Bradford Hill elements of causation. This means that some people who develop a chronic psychotic disorder after using cannabis, would not have developed the disorder had they not used cannabis. Even if there is some confounding effects, for example unquantified variations in other environmental risks or in genetic background, it is not enough to undermine the effect of cannabis as an independent risk factor for psychosis.

Visit the IASIC Library, filed under Psychosis, to find the article titled: The Bradford Hill Analysis of Causation Applied to Cannabis Use and the Development of Chronic Psychotic Disorders by Christine L. Miller, Ph.D., Catherine Antley, MD and Dean Whitlock (editor) with a review and contributions from Carsten Hjorthoj, Ph.D., Associate Professor, Copenhagen Research Center for Mental Health, University of Copenhagen.

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Leave a comment

Related Posts

Weed users nearly 25% more likely to need emergency care and hospitalization

The study, published Monday in the journal BMJ Open Respiratory Research, looked at national health records data for over 30,000 Ontario, Canada, residents between the ages of 12 and 65 over a six-year period. When compared with people who did not use marijuana, cannabis users were 22% more likely to visit an emergency department or be

Cannabis use is associated with increased risk for serious adverse health events

Although no significant association was observed between cannabis use and respiratory-related ER visits or hospitalisations, the risk of an equally important morbidity outcome, all-cause ER visit or hospitalisation, was significantly greater among cannabis users than among control individuals. Therefore, cannabis use is associated with increased risk for serious adverse health events and its recreational consumption

Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores

Products containing cannabinoids such as cannabidiol (CBD) have proliferated since 2018, when the Agriculture Improvement Act removed hemp (ie, cannabis containing <0.3% Δ9-tetrahydrocannabinol [THC]) from the US controlled substances list. Topical cannabinoid products can be purchased nationwide at retail stores and over the internet, yet research on these products is scarce. The objective of this

Cannabis-Derived Oromucosal Spray Misses in MS Spasticity Trial

Topline results were announced from a phase 3 trial evaluating the efficacy and safety of nabiximols oromucosal spray (JZP378) on clinical measures of spasticity in adults with multiple sclerosis. Nabiximols oromucosal spray is an investigational complex botanical mixture formulated from extracts of the cannabis sativa plant. The investigational treatment contains the cannabinoids delta-9-tetrahydrocannabinol (THC) and

Should the UK legalize marijuana?

After Sadiq Khan’s visit to a California cannabis farm, discussions of legalising the herb here in the UK has been brought back into the spot light. But is Mr. Khan’s glowing review of the US marijuana industry all it’s cracked up to be? The Medical Minefield speak with Michelle Leopold, whose campaigning for safer drug

Scroll to Top